Modulating radiochemical behaviour and biodistribution of 211At-FAPI via host–guest complexation
Abstract Radioastatinated fibroblast activation protein inhibitor (FAPI) ligands are promising candidates for targeted alpha therapy (TAT), yet their clinical translation is hampered by unfavourable physicochemical properties originating from conventional organotin-based astatination. The mandatory lipophilic aryl moie...